FRNRX | RGNCX | FRNRX / RGNCX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 30 years | 18 years | - |
Gain YTD | 8.038 | 4.096 | 196% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000 | 2500 | 40% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 338M | 335M | 101% |
Annual Yield % from dividends | 1.83 | 1.43 | 128% |
Returns for 1 year | 16.96 | 26.51 | 64% |
Returns for 3 years | 31.88 | 35.52 | 90% |
Returns for 5 years | 52.42 | 256.62 | 20% |
Returns for 10 years | 22.01 | 32.67 | 67% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
DILYX | 12.68 | 0.16 | +1.28% |
Davis International Y | |||
FIQKX | 10.29 | 0.06 | +0.59% |
Fidelity Advisor International Value Z | |||
QISGX | 28.61 | 0.11 | +0.39% |
Federated Hermes MDT Small Cap Growth IS | |||
LMGNX | 65.92 | 0.16 | +0.24% |
ClearBridge International Growth I | |||
SHPAX | 19.43 | -0.09 | -0.46% |
Saratoga Health & Biotechnology A |